Alpha Tau Medical Ltd. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Over the twelve months to 18 October 2026, 24 filings were filed, from 3 insiders.
The flow runs one way only: 12 sales worth €786k, from 1 insider, and no purchase. The amount is not disclosed for 6 filings. Biggest ticket of the year: €215k, sold by Levy Raphi and made public on 12 August 2026 (0.018% of market cap).
With 24 filings in twelve months, the company is more active than the median of 19 filings across the 5,813 companies we follow on the same exchange. Our records for Alpha Tau Medical Ltd. go back to 2026, with no purchases and 12 sales on the open market in total.
The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
24 of 24 declarations
Alpha Tau Medical Ltd. is a company focused on developing innovative cancer treatments using alpha radiation therapy technology. It is listed on NASDAQ under the ticker ATOU.
Purchases our model currently ranks for the recommendations list.
All recommendations